Loading True North Map…
Capability profile
OmniaBio offers cell and gene therapy manufacturing support while developing an Intelligent Factory approach to automation. The concept links predictive analytics, robotic processing, automated quality control and logistics to manufacturing workflows.
These describe the reviewed application scope, not confirmed deployments, released requirements or procurement eligibility.
The June 2026 Avectas agreement concerns evaluation within the developing Intelligent Factory. Existing manufacturing services should be distinguished from completion and validation of the full automation concept.
Biotechnology sponsors can scope process development and manufacturing services; product-specific validation and regulatory requirements remain separate from automation partnerships.
A technology readiness level is not established by the reviewed public sources.
No reviewed Mission area or released Defence need connection is currently published.
These records support this capability and its published Mission area and Defence need connections. A source count is not a count of independent confirmations.
Source type: official company news
Supports: Capability · technology readiness level
The June 2026 CCRM, OmniaBio and Avectas agreement is an evaluation of an automated manufacturing platform within the developing Intelligent Factory concept. OmniaBio offers clinical and commercial cell and gene therapy manufacturing support; product-specific process validation and regulatory requirements remain distinct from the automation evaluation.
Supports: Capability · core features
The June 2026 CCRM, OmniaBio and Avectas agreement is an evaluation of an automated manufacturing platform within the developing Intelligent Factory concept. OmniaBio offers clinical and commercial cell and gene therapy manufacturing support; product-specific process validation and regulatory requirements remain distinct from the automation evaluation.
Supports: Capability · maturity
The June 2026 CCRM, OmniaBio and Avectas agreement is an evaluation of an automated manufacturing platform within the developing Intelligent Factory concept. OmniaBio offers clinical and commercial cell and gene therapy manufacturing support; product-specific process validation and regulatory requirements remain distinct from the automation evaluation.
Supports: Capability · core features
The June 2026 CCRM, OmniaBio and Avectas agreement is an evaluation of an automated manufacturing platform within the developing Intelligent Factory concept. OmniaBio offers clinical and commercial cell and gene therapy manufacturing support; product-specific process validation and regulatory requirements remain distinct from the automation evaluation.
Supports: Capability · commercial availability
The June 2026 CCRM, OmniaBio and Avectas agreement is an evaluation of an automated manufacturing platform within the developing Intelligent Factory concept. OmniaBio offers clinical and commercial cell and gene therapy manufacturing support; product-specific process validation and regulatory requirements remain distinct from the automation evaluation.
Source type: official company product
Supports: Capability · name
OmniaBio's Intelligent Factory combines cell and gene therapy manufacturing services with proposed predictive analytics, robotics, automated quality control and logistics. The Intelligent Factory page describes an automation architecture and development direction; it does not establish regulatory approval for every tool or therapy.
Supports: Capability · defence applications
Scale-up and technology transfer for cell therapies
Supports: Capability · summary
OmniaBio's Intelligent Factory combines cell and gene therapy manufacturing services with proposed predictive analytics, robotics, automated quality control and logistics. The Intelligent Factory page describes an automation architecture and development direction; it does not establish regulatory approval for every tool or therapy.
Innovation, Science and Economic Development Canada · Jun 15, 2026
Source type: government service page
Supports: Capability · maturity
Innovation, Science and Economic Development Canada's public evidence confirms a company-specific project, award, program or operating context, while configuration-specific acceptance and scale remain bounded by the reviewer warning.
Public sources cited · Facts and assessments kept separate · Human review
Loading related records…
Supports: Capability · core features
Automation, robotics, and digital manufacturing controls
Supports: Capability · capability type
OmniaBio's Intelligent Factory combines cell and gene therapy manufacturing services with proposed predictive analytics, robotics, automated quality control and logistics. The Intelligent Factory page describes an automation architecture and development direction; it does not establish regulatory approval for every tool or therapy.
Supports: Capability · technical tags
OmniaBio's Intelligent Factory combines cell and gene therapy manufacturing services with proposed predictive analytics, robotics, automated quality control and logistics. The Intelligent Factory page describes an automation architecture and development direction; it does not establish regulatory approval for every tool or therapy.
Supports: Capability · technicaldomainslugs
True North Map maps Intelligent Factory cell-and-gene-therapy manufacturing to advanced manufacturing and integration from its documented technology functions.
Supports: Capability · defence applications
OmniaBio's Intelligent Factory combines cell and gene therapy manufacturing services with proposed predictive analytics, robotics, automated quality control and logistics. The Intelligent Factory page describes an automation architecture and development direction; it does not establish regulatory approval for every tool or therapy.
Supports: Capability · name
Intelligent Factory cell-and-gene-therapy manufacturing
Supports: Capability · commercial availability
OmniaBio currently presents Intelligent Factory cell-and-gene-therapy manufacturing through its official public capability surface.
Supports: Capability · summary
OmniaBio provides process development and GMP manufacturing services for cell and gene therapies while developing automation, robotics, analytics, and digital controls for manufacturing workflows. Planned intelligent-factory capabilities should be separated from currently validated GMP operations.
Supports: Capability · core features
GMP cell-and-gene-therapy process and manufacturing services
Supports: Capability · technical tags
OmniaBio's Intelligent Factory combines cell and gene therapy manufacturing services with proposed predictive analytics, robotics, automated quality control and logistics. The Intelligent Factory page describes an automation architecture and development direction; it does not establish regulatory approval for every tool or therapy.
Supports: Capability · defence applications
OmniaBio's Intelligent Factory combines cell and gene therapy manufacturing services with proposed predictive analytics, robotics, automated quality control and logistics. The Intelligent Factory page describes an automation architecture and development direction; it does not establish regulatory approval for every tool or therapy.
Supports: Capability · technical tags
True North Map applies the biomanufacturing tag from OmniaBio's documented capability functions.
Supports: Capability · defence applications
Domestic advanced-therapy manufacturing capacity
Supports: Capability · capability type
Source-bounded strategic technology capability
Supports: Capability · technical tags
True North Map applies the cell-and-gene-therapy tag from OmniaBio's documented capability functions.
Supports: Capability · technicaldomainslugs
OmniaBio's Intelligent Factory combines cell and gene therapy manufacturing services with proposed predictive analytics, robotics, automated quality control and logistics. The Intelligent Factory page describes an automation architecture and development direction; it does not establish regulatory approval for every tool or therapy.
Supports: Capability · core features
OmniaBio's Intelligent Factory combines cell and gene therapy manufacturing services with proposed predictive analytics, robotics, automated quality control and logistics. The Intelligent Factory page describes an automation architecture and development direction; it does not establish regulatory approval for every tool or therapy.
